Dongbang Medical Co., Ltd (KOSDAQ:240550)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,580.00
-90.00 (-1.59%)
Sep 11, 2026, 3:30 PM KST

Dongbang Medical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
28,31830,63815,36613,73618,772
Short-Term Investments
3,7262,8781,5702,745181.44
Trading Asset Securities
14.4112.0710.2710.39.59
Cash & Short-Term Investments
32,05833,52816,94516,49118,963
Cash Growth
0.04%97.86%2.76%-13.04%-
Accounts Receivable
18,97819,15816,81513,06312,741
Other Receivables
1,5761,3692,8092,133791.68
Receivables
20,75422,32719,85715,67914,032
Inventory
42,29036,43032,70729,21724,854
Prepaid Expenses
3,5941,821499.58355.49507.5
Other Current Assets
3,5052,1992,5651,6501,716
Total Current Assets
102,20196,30572,57463,39360,073
Property, Plant & Equipment
80,05767,28157,42240,99340,802
Long-Term Investments
11,85110,7458,6695,4615,011
Goodwill
2,2962,296873.01656.13656.13
Other Intangible Assets
883.88994.73957.571,0861,126
Long-Term Accounts Receivable
-16.08---
Long-Term Deferred Tax Assets
4,9254,6473,7223,4103,992
Other Long-Term Assets
4,1724,2105,9002,0002,075
Total Assets
206,441186,529150,351117,001113,736

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
7,3939,0466,2724,2708,664
Accrued Expenses
2,7152,5662,4571,8731,782
Short-Term Debt
25,08221,73024,17413,94715,178
Current Portion of Long-Term Debt
1,4682,2525,1075,2444,630
Current Portion of Leases
711.7696.84655.84421.02468.48
Current Income Taxes Payable
2,9231,5823,0381,7921,266
Other Current Liabilities
9,7567,6098,67819,23021,285
Total Current Liabilities
50,04945,48350,38346,77753,274
Long-Term Debt
10,3427,44312,61411,51913,803
Long-Term Leases
1,0911,082875.22811.82348.36
Pension & Post-Retirement Benefits
5,0064,8334,7093,7313,607
Other Long-Term Liabilities
2,5472,3721,065190190
Total Liabilities
69,04461,21369,64763,02971,222

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
10,46710,4058,7487,4207,420
Additional Paid-In Capital
67,14767,09436,1749,6109,610
Retained Earnings
54,14244,60232,87729,19119,291
Comprehensive Income & Other
2,756787.972,109567.9781.26
Total Common Equity
134,512122,88879,90946,79036,403
Minority Interest
2,8852,428795.14328.63333.76
Shareholders' Equity
137,396125,31680,70453,97242,514
Total Liabilities & Equity
206,441186,529150,351117,001113,736

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
38,69533,20443,42631,94334,428
Net Cash (Debt)
-6,637323.94-26,481-15,452-15,465
Net Cash Growth
-----
Net Cash Per Share
-315.2115.60-1636.29-883.13-1042.04
Filing Date Shares Outstanding
20.9320.8117.514.8414.84
Total Common Shares Outstanding
20.9320.8117.514.8414.84
Working Capital
52,15250,82222,19116,6166,799
Book Value Per Share
6425.535905.184567.053152.762452.91
Tangible Book Value
131,331119,59778,07945,04734,622
Tangible Book Value Per Share
6273.615747.044462.423035.352332.85
Land
10,69310,0648,4887,0847,084
Buildings
42,92428,47821,48014,95514,958
Machinery
60,93860,05354,46441,53537,911
Construction In Progress
3,6964,3308,4081,8331,122